Grufity logo
Grufity logo

Latest BML Capital Management, LLC Stock Portfolio

$155Million– No. of Holdings #15

BML Capital Management, LLC Performance:
2026 Q1: 19.38%YTD: 19.38%2025: -8.75%
Performance for 2026 Q1 is 19.38%, and YTD is 19.38%, and 2025 is -8.75%.

About BML Capital Management, LLC and 13F Hedge Fund Stock Holdings

On 2026-05-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $155.8 Millions as of 31 Mar, 2026.

The top stock holdings of BML Capital Management, LLC are ACRS, AVIR, ORMP. The fund has invested 34.3% of it's portfolio in ACLARIS THERAPEUTICS INC and 24.4% of portfolio in ATEA PHARMACEUTICALS INC.

The fund managers got completely rid off LISATA THERAPEUTICS INC (CLBS) stocks. They significantly reduced their stock positions in ATEA PHARMACEUTICALS INC (AVIR). BML Capital Management, LLC opened new stock positions in TILLYS INC (TLYS), KRAFT HEINZ CO (KHC) and JANUX THERAPEUTICS INC (JANX). The fund showed a lot of confidence in some stocks as they added substantially to OUTSET MED INC (OM), IMAGENEBIO INC (IKNA) and PMV PHARMACEUTICALS INC (PMVP).
BML Capital Management, LLC Equity Portfolio Value
Last Reported on: 06 May, 2026

BML Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that BML Capital Management, LLC made a return of 19.38% in the last quarter. In trailing 12 months, it's portfolio return was 39.45%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
tillys inc8,707,500
kraft heinz co2,811,250
janux therapeutics inc2,153,960
New stocks bought by BML Capital Management, LLC

Additions

Ticker% Inc.
outset med inc250
imagenebio inc13.39
pmv pharmaceuticals inc0.53
Additions to existing portfolio by BML Capital Management, LLC

Reductions

Ticker% Reduced
atea pharmaceuticals inc-5.76
BML Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
lisata therapeutics inc-136,427
BML Capital Management, LLC got rid off the above stocks

Sector Distribution

BML Capital Management, LLC has about 84.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Consumer Cyclical
  • Consumer Defensive
Sector%
Healthcare84.8
Consumer Cyclical9.7
Consumer Defensive4.7

Market Cap. Distribution

BML Capital Management, LLC has about 4.7% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MICRO-CAP
  • NANO-CAP
  • LARGE-CAP
  • MID-CAP
Category%
SMALL-CAP60.2
MICRO-CAP21.2
NANO-CAP9
LARGE-CAP4.7
MID-CAP4.1

Stocks belong to which Index?

About 89% of the stocks held by BML Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200080.1
Others11
S&P 5008.9
Top 5 Winners (%)%
AVIR
atea pharmaceuticals inc
49.2 %
ACRS
aclaris therapeutics inc
24.6 %
TGT
target corp
24.0 %
ORMP
oramed pharmaceuticals inc
19.3 %
KZR
kezar life sciences inc
18.0 %
Top 5 Winners ($)$
AVIR
atea pharmaceuticals inc
13.2 M
ACRS
aclaris therapeutics inc
10.5 M
ORMP
oramed pharmaceuticals inc
1.7 M
TGT
target corp
0.9 M
KZR
kezar life sciences inc
0.8 M
Top 5 Losers (%)%
IKNA
imagenebio inc
-26.3 %
TIL
instil bio inc
-25.1 %
connect biopharma hldgs ltd
-7.1 %
PMVP
pmv pharmaceuticals inc
-0.8 %
Top 5 Losers ($)$
TIL
instil bio inc
-1.8 M
IKNA
imagenebio inc
-0.4 M
connect biopharma hldgs ltd
-0.1 M
PMVP
pmv pharmaceuticals inc
-0.1 M

BML Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BML Capital Management, LLC

BML Capital Management, LLC has 15 stocks in it's portfolio. About 94% of the portfolio is in top 10 stocks. TIL proved to be the most loss making stock for the portfolio. AVIR was the most profitable stock for BML Capital Management, LLC last quarter.

Last Reported on: 06 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions